Press Releases
Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy RALEIGH, N.C.; Dec. 7, 2021 – Veranex, the only global, tech-enabled...
Veranex Announces Acquisition of IMMR
RALEIGH, N.C.; Oct. 12, 2021 – Veranex, the first concept-to-commercialization global service provider dedicated to the MedTech industry, today announced...
Veranex Announces Acquisition of Experien Group
RALEIGH, N.C.; August 3, 2021 – Veranex the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced...
Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization MedTech Services Company
RALEIGH, N.C.; June 16, 2021 – Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to...
Quartesian Signs Global Medical Technology Company to Multiyear Clinical Data Management Services Agreement
PRINCETON, N.J., April 13, 2021 — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device industries,...
Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial
PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device...
News Coverage
Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy RALEIGH, N.C.; Dec. 7, 2021 – Veranex, the only global, tech-enabled...
How Long Does It Take to Register a Medical Device/IVD in China?
This article generalizes the process to provide a hyper-simplified answer for investors and CEOs, and sales & marketing executives of MedTech companies, needing this crucial piece of information to make…
Winter Has Come – Aggressive National Programs To Drive Down Drug Costs
China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along…
Defining the value of innovative treatment methods in Germany
A recent proposal by Jens Spahn, Federal Minister for Health in Germany, would limit the decision-making power of the Joint Federal Committee (G-BA) and lead to new evidence approaches for…
